Eagle Veterinary Technology이글벳
044960 · KOSDAQ · ₩044960 · 이글벳
₩3,025▲ ₩25 (0.83%)End-of-day · Oct 27, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩43B | ₩42B | ₩43B | ₩44B | ₩40B |
| Cost of sales | ₩29B | ₩28B | ₩28B | ₩29B | ₩26B |
| Gross profit | ₩15B | ₩14B | ₩15B | ₩15B | ₩14B |
| Operating income | ₩4.3B | ₩3.5B | ₩3.3B | ₩3.6B | ₩4.2B |
| Net income | ₩3.9B | ₩3.7B | ₩3B | ₩2.6B | ₩3.6B |
| Net income to shareholders | ₩3.9B | ₩3.7B | ₩3B | ₩2.6B | ₩3.6B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩64B | ₩61B | ₩58B | ₩55B | ₩53B |
| Current assets | ₩31B | ₩28B | ₩26B | ₩26B | ₩27B |
| Cash and equivalents | ₩4.5B | ₩2.8B | ₩2.6B | ₩1.7B | ₩2.3B |
| Total liabilities | ₩12B | ₩13B | ₩13B | ₩12B | ₩12B |
| Current liabilities | ₩8.6B | ₩10B | ₩9.8B | ₩8.2B | ₩8.3B |
| Borrowings | ₩5B | ₩5.2B | ₩5.5B | ₩5.5B | ₩5B |
| Total equity | ₩52B | ₩49B | ₩45B | ₩43B | ₩41B |
| Shareholders' equity | ₩52B | ₩49B | ₩45B | ₩43B | ₩41B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩5.5B | ₩4.3B | ₩4.9B | −₩318M | ₩6.1B |
| Free cash flow | ₩5.5B | ₩4.3B | ₩4.9B | −₩318M | ₩6.1B |
| Dividends paid | ₩736M | ₩491M | ₩491M | ₩614M | ₩491M |
Consolidated where available. Amounts in won.
Also known as: Eagle Veterinary Technology / 이글벳 / 044960 / KRX:044960
Source: KRX statistical information